Snowden Capital Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-34,508
| Closed | -$325K | – | 1224 |
|
|
2024
Q4 | $325K | Sell |
34,508
-452
| -1% | -$4.26K | 0.01% | 949 |
|
|
2024
Q3 | $373K | Sell |
34,960
-15,104
| -30% | -$161K | 0.01% | 899 |
|
|
2024
Q2 | $497K | Buy |
50,064
+299
| +0.6% | +$2.97K | 0.01% | 756 |
|
|
2024
Q1 | $586K | Sell |
49,765
-833
| -2% | -$9.81K | 0.02% | 691 |
|
|
2023
Q4 | $718K | Sell |
50,598
-3,011
| -6% | -$42.7K | 0.03% | 538 |
|
|
2023
Q3 | $652K | Sell |
53,609
-4,452
| -8% | -$54.1K | 0.03% | 531 |
|
|
2023
Q2 | $729K | Sell |
58,061
-555
| -0.9% | -$6.97K | 0.03% | 569 |
|
|
2023
Q1 | $650K | Buy |
58,616
+768
| +1% | +$8.52K | 0.03% | 615 |
|
|
2022
Q4 | $706K | Buy |
57,848
+18,535
| +47% | +$226K | 0.03% | 554 |
|
|
2022
Q3 | $410K | Buy |
39,313
+12,804
| +48% | +$134K | 0.02% | 735 |
|
|
2022
Q2 | $284K | Buy |
+26,509
| New | +$284K | 0.01% | 894 |
|